Affinity Health Group, LLC
Affinity Health Group, LLC was paid $34.73M by Medicaid between Jan 2018 and Sep 2024, across 223 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoAFFINITY HEALTH GROUP, LLC
MONROE, LA 71201
MONROE, LA 71201
33aNPI1023291226assigned 12/11/2007
33bProvider typeSpeech-Language Pathologist
28Total paid$34.73M
24GClaims1,628,609
24DCodes billed223
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Speech-Language Pathologist providers in Louisiana
Rank by total paid#1 of 217
Median peer was paid$135K
This provider vs. median257×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 240,670 | $4.49M | |
| 2019 | 225,275 | $5.24M | |
| 2020 | 206,137 | $4.79M | |
| 2021 | 226,745 | $5.57M | |
| 2022 | 276,204 | $5.85M | |
| 2023 | 299,850 | $5.56M | |
| 2024incomplete | 153,728 | $3.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 143,250 | 120,032 | $10.87M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 169,431 | 148,054 | $9.91M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.0% | 14,563 | 12,839 | $1.73M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.7% | 20,447 | 17,604 | $1.30M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 17,307 | 16,522 | $1.21M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 17,817 | 16,308 | $1.11M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 30,373 | 26,116 | $1.01M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 10,450 | 9,559 | $905K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 41,645 | 38,371 | $587K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 7,170 | 6,816 | $484K |
| 80050 | General health panel | 1.4% | 18,431 | 17,210 | $469K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 16,140 | 14,278 | $438K |
211 more codes
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.2% | 24,277 | $426K |
| 99051 | 1.1% | 26,069 | $378K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16,511 | $345K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 6,441 | $337K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 4,936 | $283K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 44,903 | $263K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 5,010 | $218K |
| 80061 | Lipid panel | <1% | 25,195 | $207K |
| 87634 | <1% | 4,037 | $203K | |
| 90837 | Psychotherapy session, about an hour | <1% | 3,970 | $189K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,625 | $87K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,448 | $77K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,063 | $77K |
| 99460 | <1% | 1,515 | $71K | |
| 80053 | Comprehensive metabolic panel | <1% | 10,768 | $69K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,540 | $62K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 40,624 | $61K |
| 20611 | <1% | 1,205 | $56K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,262 | $56K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 7,937 | $52K |
| 90474 | <1% | 5,773 | $50K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 601 | $48K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,569 | $44K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,904 | $42K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,257 | $41K |
| 93000 | <1% | 4,848 | $40K | |
| 20610 | <1% | 1,548 | $39K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,183 | $37K |
| 92928 | <1% | 269 | $36K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,409 | $35K |
| 81001 | <1% | 15,419 | $32K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 177 | $29K |
| 99223 | Prolong inpt eval add15 m | <1% | 616 | $28K |
| 83655 | <1% | 2,479 | $28K | |
| 31231 | <1% | 363 | $27K | |
| 73564 | <1% | 1,571 | $27K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 497 | $27K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 4,695 | $25K |
| 92551 | <1% | 3,037 | $23K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,004 | $22K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 737 | $20K |
| 92557 | <1% | 924 | $20K | |
| 92567 | <1% | 2,455 | $19K | |
| 99381 | <1% | 271 | $18K | |
| 99205 | Prolong outpt/office vis | <1% | 129 | $17K |
| 93016 | <1% | 1,464 | $16K | |
| 81003 | <1% | 10,875 | $15K | |
| 90686 | <1% | 16,378 | $15K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 302 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 451 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 449 | $13K |
| 3074F | <1% | 159,385 | $13K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 514 | $13K |
| 82728 | <1% | 1,166 | $12K | |
| 81025 | <1% | 2,535 | $12K | |
| 93018 | <1% | 1,460 | $11K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,698 | $10K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 231 | $10K |
| 3078F | <1% | 138,054 | $10K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 491 | $9K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 119 | $8K |
| 99173 | <1% | 4,190 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 515 | $8K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 293 | $7K |
| 0012A | <1% | 335 | $7K | |
| 99385 | <1% | 122 | $7K | |
| 3079F | <1% | 65,803 | $7K | |
| 0001A | <1% | 185 | $7K | |
| 69210 | <1% | 404 | $7K | |
| 0011A | <1% | 321 | $7K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 387 | $6K |
| 0002A | <1% | 163 | $6K | |
| 11721 | <1% | 862 | $6K | |
| 84439 | <1% | 822 | $6K | |
| 87807 | <1% | 466 | $5K | |
| 82962 | <1% | 3,878 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 542 | $5K |
| 0071A | <1% | 118 | $5K | |
| 86308 | <1% | 1,170 | $5K | |
| 99383 | <1% | 57 | $4K | |
| 72100 | <1% | 256 | $4K | |
| 3044F | <1% | 2,148 | $4K | |
| 82607 | <1% | 365 | $4K | |
| 83540 | <1% | 944 | $4K | |
| 83880 | <1% | 120 | $4K | |
| 3075F | <1% | 32,147 | $4K | |
| 99386 | <1% | 49 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 166 | $4K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 8,668 | $4K |
| 93922 | <1% | 130 | $3K | |
| 0072A | <1% | 64 | $3K | |
| 83550 | <1% | 417 | $3K | |
| 82570 | <1% | 1,026 | $3K | |
| 93244 | <1% | 176 | $3K | |
| 96127 | <1% | 11,350 | $3K | |
| 90785 | <1% | 1,099 | $3K | |
| 93272 | <1% | 141 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 640 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,780 | $2K |
| 82043 | <1% | 508 | $2K | |
| 3077F | <1% | 17,814 | $2K | |
| 74018 | <1% | 151 | $2K | |
| 82746 | <1% | 186 | $2K | |
| 86580 | <1% | 444 | $2K | |
| 90688 | <1% | 135 | $2K | |
| 31575 | <1% | 27 | $2K | |
| 73110 | <1% | 100 | $2K | |
| 11720 | <1% | 309 | $2K | |
| 93458 | <1% | 13 | $2K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 87 | $1K |
| 83735 | <1% | 303 | $1K | |
| 93227 | <1% | 83 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 325 | $1K |
| 93454 | <1% | 12 | $1K | |
| 73562 | <1% | 85 | $1K | |
| 92587 | <1% | 42 | $1K | |
| 86140 | <1% | 306 | $1K | |
| 0081A | <1% | 29 | $1K | |
| 84153 | <1% | 80 | $889.38 | |
| 99152 | <1% | 845 | $877.45 | |
| 73130 | <1% | 58 | $780.08 | |
| 90473 | <1% | 83 | $750.96 | |
| 0064A | <1% | 33 | $749.24 | |
| 85651 | <1% | 309 | $703.86 | |
| 72040 | <1% | 53 | $699.60 | |
| 99406 | <1% | 242 | $688.12 | |
| 3080F | <1% | 8,305 | $685.50 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 112 | $661.63 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17 | $631.34 |
| 29515 | <1% | 19 | $611.76 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 437 | $584.03 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 10,000 | $581.52 |
| 29125 | <1% | 12 | $540.96 | |
| 93242 | <1% | 69 | $512.24 | |
| 97161 | <1% | 12 | $471.52 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 27 | $438.77 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 422 | $414.70 |
| 73030 | <1% | 38 | $413.49 | |
| 99462 | <1% | 16 | $404.09 | |
| 84481 | <1% | 46 | $326.08 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 41 | $294.89 |
| 90734 | <1% | 153 | $267.80 | |
| 92552 | <1% | 25 | $260.21 | |
| 82465 | <1% | 63 | $246.81 | |
| 83718 | <1% | 26 | $203.75 | |
| 11719 | <1% | 221 | $199.56 | |
| 73610 | <1% | 15 | $196.00 | |
| 51798 | <1% | 32 | $195.23 | |
| 94010 | <1% | 15 | $186.34 | |
| 82247 | <1% | 47 | $171.45 | |
| 92555 | <1% | 12 | $142.11 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 2,391 | $122.74 |
| 11056 | <1% | 28 | $113.84 | |
| 93296 | <1% | 66 | $112.32 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 74 | $91.16 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 229 | $55.64 |
| 82550 | <1% | 12 | $45.36 | |
| 3051F | <1% | 49 | $40.00 | |
| 70220 | <1% | 14 | $26.39 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 168 | $13.51 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 26 | $8.61 |
| 99053 | <1% | 7,747 | $2.41 | |
| 90633 | <1% | 6,094 | $1.01 | |
| 90677 | <1% | 1,458 | $0.65 | |
| 91301 | <1% | 500 | $0.09 | |
| 90647 | <1% | 10,611 | $0.04 | |
| 90378 | <1% | 13 | $0.03 | |
| 90651 | <1% | 539 | $0.03 | |
| 1159F | 0% | 10,703 | $0.00 | |
| 1160F | 0% | 10,679 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 127,227 | $0.00 |
| 90700 | 0% | 1,500 | $0.00 | |
| 90670 | 0% | 12,914 | $0.00 | |
| 90681 | 0% | 5,486 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 6,336 | $0.00 |
| 4004F | 0% | 885 | $0.00 | |
| 90710 | 0% | 498 | $0.00 | |
| 90707 | 0% | 1,520 | $0.00 | |
| VH100 | 0% | 57 | $0.00 | |
| 91300 | 0% | 444 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 19 | $0.00 |
| 90662 | 0% | 51 | $0.00 | |
| 90715 | 0% | 42 | $0.00 | |
| 91308 | 0% | 72 | $0.00 | |
| 90685 | 0% | 193 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 27 | $0.00 |
| 90672 | 0% | 92 | $0.00 | |
| 0518F | 0% | 12 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 37,847 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 6,838 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 15,057 | $0.00 |
| 90723 | 0% | 10,639 | $0.00 | |
| 1036F | 0% | 4,925 | $0.00 | |
| 1111F | 0% | 695 | $0.00 | |
| 91307 | 0% | 371 | $0.00 | |
| 90696 | 0% | 282 | $0.00 | |
| 99024 | 0% | 3,899 | $0.00 | |
| 90716 | 0% | 1,502 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,925 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 319 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 126 | $0.00 |
| 4000F | 0% | 137 | $0.00 | |
| 97010 | 0% | 86 | $0.00 | |
| 90656 | 0% | 132 | $0.00 | |
| 91305 | 0% | 12 | $0.00 | |
| 99345 | Prolong home eval add 15m | 0% | 17 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 67 | $0.00 |
| 90619 | 0% | 17 | $0.00 | |
| 90620 | 0% | 14 | $0.00 | |
| WELL2 | 0% | 28 | $0.00 | |
| 99000 | 0% | 68 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBREARD, MIKE (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Affinity Health Group, LLC | Monroe, LA | $198K |
| Affinity Health Group, LLC | Monroe, LA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.